The rapid scientific interest in gut microbiota (GM) has coincided with a global increase in
the prevalence of infectious and non-infectivous liver diseases. GM, which is also called “the …

The liver is a key, frontline immune tissue. Ideally positioned to detect pathogens entering
the body via the gut, the liver appears designed to detect, capture, and clear bacteria …

Hepatocellular carcinoma is the most prevalent form of primary liver cancer with a
multifactorial aetiology comprising genetic, environmental, and behavioural factors. Evading …

Background Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer and
a leading cause of cancer-related deaths worldwide. The major risk factors for HCC …

The incidence rate of hepatocellular carcinoma (HCC) is rising. It is one of the most common
cancers worldwide and accounts for substantial morbidity and mortality. Chronic hepatitis B …

The incidence of hepatocellular carcinoma (HCC) is increasing in industrialized societies;
this is likely secondary to the increasing burden of non-alcoholic fatty liver disease (NAFLD) …

Nonalcoholic fatty liver disease (NAFLD) is a heterogeneous and complex disease that is
imprecisely diagnosed by liver biopsy. NAFLD covers a spectrum that ranges from simple …

Type 2 diabetes mellitus is a recognized risk factor for HCC in patients with liver disease,
independent from the etiology of their liver disease. Hence, prevention and treatment of type …

Liver disease is the spectrum of liver damage ranging from simple steatosis called as
nonalcoholic fatty liver disease (NAFLD) to hepatocellular carcinoma (HCC). Clinically …

Background & Aims The progression of hepatosteatosis to non-alcoholic steatohepatitis
(NASH) is a critical step in the pathogenesis of hepatocellular cancer. However, the …